Effect of specific M1, M2 muscarinic receptor agonists on REM sleep generation.

Brain Research
J Velazquez-MoctezumaP Shiromani

Abstract

Specific agonists for muscarinic receptor subtypes were infused by microinjection into the medial pontine reticular formation of freely moving cats. The M2 agonists Oxotremorine-M and Cisdioxolane significantly increased REM sleep percentage. The results obtained with microinfusions of carbachol, a mixed muscarinic agonist, were similar to that obtained by the M2 agonists. The M1 agonist McN-A-343 did not elicit any change in sleep or REM sleep percentage. The generation of REM sleep by cholinergic stimulation of the medial pontine reticular formation may be mediated by the M2 muscarinic receptor subtype.

References

Apr 1, 1987·Pharmacology, Biochemistry, and Behavior·J J HaganC L Broekkamp
Oct 29, 1986·Brain Research·P J Shiromani, D J McGinty
Apr 6, 1984·Neuroscience Letters·J M SiegelK S Tomaszewski
Dec 1, 1964·International Journal of Neuropharmacology·R GEORGED J JENDEN

❮ Previous
Next ❯

Citations

Jan 1, 1992·Psychopharmacology·R J Salin-PascualR Drucker-Colin
Nov 16, 2011·Pflügers Archiv : European journal of physiology·Pierre-Hervé LuppiPatrice Fort
Jul 23, 1991·European Journal of Pharmacology·Y Lin, J W Phillis
Jan 1, 1994·Journal of Psychosomatic Research·D RiemannM Berger
Sep 1, 1993·Pharmacology, Biochemistry, and Behavior·J Velazquez-MoctezumaO Diaz-Ruiz
Nov 1, 1995·Pharmacology, Biochemistry, and Behavior·L L LoboS Tufik
Jan 1, 1995·Neuroscience and Biobehavioral Reviews·S Datta
Mar 1, 1994·Psychiatry Research·D RiemannJ B Aldenhoff
May 1, 1996·Brain Research. Molecular Brain Research·P J ShiromaniR W McCarley
Nov 1, 1993·Progress in Neurobiology·M S Aldrich
Oct 1, 1995·Progress in Neurobiology·N B ReeseR D Skinner
Jul 31, 1990·Neuroscience Letters·J Velazquez-MoctezumaP J Shiromani
Jun 24, 1998·Brain Research. Molecular Brain Research·M A GrecoP J Shiromani
May 1, 1997·Progress in Neurobiology·S Nishino, E Mignot
Jul 17, 2001·Biological Psychology·D RiemannU Voderholzer
Dec 1, 1993·Journal of Sleep Research·M Berger, D Riemann
Mar 1, 1997·The European Journal of Neuroscience·K Sakai, H Onoe
Aug 20, 2005·Neuropsychobiology·Romain GoutagnyPatrice Fort
Jan 9, 2003·Pharmacogenomics·Mehdi Tafti, Yves Dauvilliers
Apr 17, 2012·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Matthew R Ebben, Ana C Krieger
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·S E HamiltonN M Nathanson
Apr 24, 2012·Progress in Neurobiology·Birendra Nath MallickMudasir Ahmad Khanday
May 29, 2009·The European Journal of Neuroscience·P FortP-H Luppi
Jul 2, 2008·Annals of the New York Academy of Sciences·Barbara E Jones

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.